What is the Share Price of Ind-Swift Laboratories Ltd?

Ind-Swift Laboratories Ltd share price is ₹69.90 As on 09 May, 2025|08:28

Home
>
Stocks
>
Ind-Swift Laboratories Ltd

Ind-Swift Laboratories Ltd Share Price

Q: What is the Market Cap of Ind-Swift Laboratories Ltd?

The Market Cap of Ind-Swift Laboratories Ltd is ₹425 As on 09 May, 2025|08:28

Q: What is PE Ratio of Ind-Swift Laboratories Ltd?

The P/E ratio of Ind-Swift Laboratories Ltd is 5.14 As on 09 May, 2025|08:28

Q: What is PB Ratio of Ind-Swift Laboratories Ltd?

The PB ratio of Ind-Swift Laboratories Ltd is 0.41 As on 09 May, 2025|08:28

₹ 69.90 -1.77 (-2.47%)
Updated on 09-05-2025 8:25 AM

Stock Rating

Pros 2

Cons 7

Ind-Swift Laboratories Ltd Price Performance

Day's Low
₹69.5

Day's High
₹73.33

₹ 69.9

52-w low
₹69.5

52-w high
₹186

69.9

Day's open
₹72.24
Previous close
₹71.669998
VWAP
₹71.17
Lower price band
₹56.1
Upper price band
₹84.15

Today's Market Action

The last traded share price of Ind-Swift Laboratories Ltd was 69.90 down by -2.47% on the NSE. Its last traded stock price on BSE was 70.44 down by -2.11%. The total volume of shares on NSE and BSE combined was 901,418 shares. Its total combined turnover was Rs 6.42 crores.

Ind-Swift Laboratories Ltd Medium and Long Term Market Action

Ind-Swift Laboratories Ltd hit a 52-week high of 186 on 02-08-2024 and a 52-week low of 69.5 on 09-05-2025. The stock price of Ind-Swift Laboratories Ltd is down by -15% over the last one month. It is down by -37% over the last one year. Don't forget to check the full stock price history in the table below.

Ind-Swift Laboratories Ltd Fundamentals

Market Cap (Cr): 425
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Ind-Swift Laboratories Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Ind-Swift Laboratories Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Ind-Swift Laboratories Ltd

Data not available.

Ind-Swift Laboratories Ltd FAQ's

What is Share Price of Ind-Swift Laboratories Ltd?

What is the Market Cap of Ind-Swift Laboratories Ltd?

What is PE Ratio of Ind-Swift Laboratories Ltd?

What is PB Ratio of Ind-Swift Laboratories Ltd?

What is the CAGR of Ind-Swift Laboratories Ltd?

How to Buy Ind-Swift Laboratories Ltd Share?

Can I buy Ind-Swift Laboratories Ltd from Samco?

How do I buy Ind-Swift Laboratories Ltd from Samco?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Asset Light Business
The company operates a great asset light business with a high Asset turnover ratio of 149.00. A high asset turnover ratio is a great driver of RoE and can improve shareholder returns. A relatively higher asset turnover ratio also will result in lower dilution as the business grows its revenues as earnings.
Zero Debt
The company has almost nil to negligible debt to equity ratio of 0.02. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.

Cons

Momentum Strength
The stock is currently exhibiting weak momentum, & is showing weak relative strength.
Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Poor Cash Flow Conversion
The business has very poor cash conversion ratio of only -23.76% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
Low Interest Coverage
The company has a very low Interest coverage ratio of 4.94 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
Highly Cyclical Industry
The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
Poor Capital Allocation
The company has disproportionately high amount of assets locked up in working capital, cash and cash equivalents, loans and advances, etc to the extent of 89.87 % of total assets. This reflects poorly on the capital allocation strategy of the management which negatively impacts shareholder returns.

Valuation Analysis

Margin of safety
(09/05/2025)

111

Margin of Safety Index: Very High

0% People are bullish about Ind-Swift Laboratories Ltd

0 % People are bearish about Ind-Swift Laboratories Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %